Sarah T Diepstraten 33rd Lorne Cancer Conference 2021

Abstracts this author is presenting:

• Identifying factors which confer resistance to BH3-mimetic drugs targeting MCL-1 in MYC-driven lymphomas — Morning Tea and E-Poster Presentations